A Frontier of Possibility: Openly Approaching the Opportunities of Psychedelic-Assisted Therapy
Ingmar Gorman, PhD, is a clinical psychologist with a specialization in psychedelic research and psychotherapy and the chief executive officer and lead trainer at Fluence, a leading psychedelic psychotherapy training company. Dr. Gorman's extensive education and clinical training were acquired at prestigious institutions such as the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. His postdoctoral fellowship at New York University, supported by the NIH, further solidified his expertise in the field.
Dr. Gorman's significant contributions include his roles as a study therapist and site co-principal investigator in Phase 2 and Phase 3 clinical trials of MDMA-assisted Psychotherapy for PTSD. An accomplished author, he has contributed to the body of knowledge on classic psychedelics, ketamine, MDMA, and the practices of Psychedelic Harm Reduction and Integration, co-authoring treatment manuals for clinical trials on substances like 5-MeO-DMT, psilocybin, and their applications in treating various disorders.
Through his work at Fluence and beyond, Dr. Gorman remains at the forefront of advancing psychedelic-assisted psychotherapy, offering training and insights grounded in the latest research and clinical practices. His website is ingmargorman.com
Time left to enjoy this video for free:
Let us know what you think...